Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration.

Core Evid · 2008 · PMC3012443 · PMID 21221192

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significantP =0.051so close (0.05 < p ≤ 0.1)

The change in retinal thickness as measured by OCT correlated with improvements in VA; a significant correlation was found with the Pearson analysis (r=0.38, P =0.016), although the Spearman analysis was found to be borderline significant (r=0.31, P =0.051).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.